Eileen M. O’Reilly

Scientific Advisor at Thetis Pharma

Dr. Eileen M. O’Reilly holds the Winthrop Rockefeller Endowed Chair in Medical Oncology at Memorial Sloan Kettering (MSK). She serves as the Section Head for Hepatopancreaticobiliary/Neuroendocrine Cancers, Gastrointestinal Oncology Service, Co-Director for Medical Initiatives at the David M. Rubenstein Center for Pancreatic Cancer and is an Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College.

Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland. She completed her residency training in Ireland and Fellowship training at MSK. Dr. O’Reilly has pancreatic and hepatobiliary malignancies as the major focus of her research and clinical activities. Research directions include the integration of molecular and genetic-based therapies for the treatment of pancreatic cancer along with the development of adjuvant and neoadjuvant therapies and the identification of biomarkers for therapy selection. Dr. O’Reilly teaches and mentors junior faculty, oncology fellows, residents and medical/other students and has numerous teaching and other awards. Dr.

O’Reilly is the Principal Investigator of multiple trials in pancreas cancer and has authored/co-authored > 300 articles, editorials and book chapters.

Timeline

  • Scientific Advisor

    Current role